Cargando…
EZH2: An Accomplice of Gastric Cancer
SIMPLE SUMMARY: Enhancer of zeste homolog 2 (EZH2) modifies the trimethylation of Lys-27 of histone 3, affecting downstream target genes’ expression. It was reported that EZH2 is highly expressed in gastric cancer and may be a potential prognostic molecule and promising therapeutic target. We aim to...
Autores principales: | Yu, Wuhan, Liu, Ning, Song, Xiaogang, Chen, Lang, Wang, Mancai, Xiao, Guohui, Li, Tengfei, Wang, Zheyuan, Zhang, Youcheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856299/ https://www.ncbi.nlm.nih.gov/pubmed/36672374 http://dx.doi.org/10.3390/cancers15020425 |
Ejemplares similares
-
The Extracellular Matrix: An Accomplice in Gastric Cancer Development and Progression
por: Moreira, Ana Margarida, et al.
Publicado: (2020) -
Fecal microbiota transplantation for irritable bowel syndrome: a systematic review and meta-analysis of randomized controlled trials
por: Wang, Mancai, et al.
Publicado: (2023) -
Tumors' accomplices in invasion
por: Sedwick, Caitlin
Publicado: (2007) -
Excessive intake of sugar: An accomplice of inflammation
por: Ma, Xiao, et al.
Publicado: (2022) -
Cancer-associated fibroblasts as accomplices to confer therapeutic resistance in cancer
por: Wang, Wenyu, et al.
Publicado: (2022)